Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Miami ,Florida ,United States ,Australia ,Japan ,Canada ,Lyvonne Briggs ,Bruce Voss ,Brenda Cooperstone ,Linkedin ,National Organization For Rare Disorders ,European Commission ,Drug Administration ,Pfizer Global Product Development ,Health Inc ,Nasdaq ,Exchange Commission ,Pfizer ,Youtube ,Australia Therapeutic Goods Administration ,Pfizer Inc ,Japan Ministry Of Health ,Health Canada ,Committee For Medicinal Products Human Use ,Complete Response Letter ,Biologics License Application ,Chief Development Officer ,Rare Disease ,Pfizer Global Product ,Therapeutic Goods Administration ,Medicinal Products ,Human Use ,Breakthroughs That Change Patient ,Pfizer News ,Annual Report ,Looking Information ,Factors That May Affect Future ,Growth Hormone ,Accessed August ,Opin Endocrinol Diabetes ,South Dartmouth ,Pfizer Media ,Business Wire ,Business ,Health ,